| Autor: |
Cozzarelli, S. Verdesoto, Canelo‐Vilaseca, M., Verge‐Almuni, J., Kelleher, N., Domenech, E. Domingo, Ramos, A. C. Oliveira, Lopez‐Pereira, P., Mussetti, A., Blazquez, I., Esteller, F. Climent, Gomez, C. Aguilera, Marti, M. T. Encuentra, Cia, J. Sancho, Sole, J. Rovira, Teigell, L. Escoda, Ramirez, G. Bustamante, Sierra, L. M. Abenoza, Pérez, M. E. Cabezudo, Montaño, A. Aranda, Pérez, S. Sánchez |
| Předmět: |
|
| Zdroj: |
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p751-752, 2p |
| Abstrakt: |
Progression Free Survival (PFS) and Overall Survival (OS) were determined by the Kaplan-Meier method, and differences in actuarial survival were analyzed by the log-rank method. B Introduction: b Survival of mantle cell lymphoma (MCL) patients has improved in recent years, although it remains an incurable disease. B Patient and Methods: b From January 2000 to May 2022, 24 patients with Ann-Arbor stage I-II MCL (out of 306 patients) were identified at the centers of the Catalan Institute of Oncology in Spain. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text